Methylcobalamin (mecobalamin, MeCbl, or MeB12) is a cobalamin, a form of vitamin B12. It differs from cyanocobalamin in that the cyano at the cobalt is replaced with a methyl group. Methylcobalamin features an octahedral cobalt(III) centre and can be obtained as bright red crystals. From the perspective of coordination chemistry, methylcobalamin is notable as a rare example of a compound that contains metal-alkyl bonds. Nickel-methyl intermediates have been proposed for the final step of methanogenesis.
|AHFS/Drugs.com||International Drug Names|
|oral, sublingual, injection.|
|Chemical and physical data|
|Molar mass||1344.40 g/mol|
|(what is this?)|
Methylcobalamin that is ingested is not used directly as a cofactor, but is first converted by MMACHC into cob(II)alamin. Cob(II)alamin is then later converted into the other 2 forms, adenosylcobalamin and methylcobalamin for use as cofactors. That is, methylcobalamin is first dealkylated and then regenerated.
This vitamer is one of two active coenzymes used by vitamin B12-dependent enzymes and is the specific vitamin B12 form used by 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), also known as methionine synthase.
Methylcobalamin participates in the Wood-Ljungdahl pathway, which is a pathway by which some organisms utilize carbon dioxide as their source of organic compounds. In this pathway, methylcobalamin provides the methyl group that couples to carbon monoxide (derived from CO2) to afford acetyl-CoA. Acetyl-CoA is a derivative of acetic acid that is converted to more complex molecules as required by the organism.
Methylcobalamin is produced by some bacteria. It plays an important role in the environment. In the environment, it is responsible for the biomethylation of certain heavy metals. For example, the highly toxic methylmercury is produced by the action of methylcobalamin. In this role, methylcobalamin serves as a source of "CH3+".
A lack of methylcobalamin can lead to megaloblastic anemia and subacute combined degeneration of the spinal cord.
- L. R. McDowell, Vitamins in animal and human nutrition
- David Dophin. Preparation of the Reduced Forms of Vitamin B12 and of Some Analogs of the Vitamin B12 Coenzyme Containing a Cobalt-Carbon Bond. D.B. McCormick and L.D. Wright, Eds. 1971;Vol. XVIII:34-54.
- "A Human Vitamin B12 Trafficking Protein Uses Glutathione Transferase Activity for Processing Alkylcobalamins". Journal of Biological Chemistry. 284: 33418–33424. doi:10.1074/jbc.M109.057877.
- "Processing of alkylcobalamins in mammalian cells: A role for the MMACHC (cblC) gene product". Molecular Genetics and Metabolism. 97: 260–266. doi:10.1016/j.ymgme.2009.04.005.
- "Genetic disorders of vitamin B12 metabolism: eight complementation groups – eight genes". Expert Reviews in Molecular Medicine. 12. doi:10.1017/S1462399410001651.
- Thakkar, K.; Billa, G. (2015-01-01). "Treatment of vitamin B12 deficiency-methylcobalamine? Cyancobalamine? Hydroxocobalamin?-clearing the confusion". European Journal of Clinical Nutrition. 69 (1): 1–2. ISSN 1476-5640. PMID 25117994. doi:10.1038/ejcn.2014.165.
- Fontecilla-Camps, J. C.; Amara, P.; Cavazza, C.; Nicolet, Y.; Volbeda, A. (2009). "Structure–function relationships of anaerobic gas-processing metalloenzymes". Nature. 460 (7257): 814–822. PMID 19675641. doi:10.1038/nature08299.
- Zenon Schneider, Andrzej Stroiński, Comprehensive B12: Chemistry, Biochemistry, Nutrition, Ecology, Medicine
- Bémeur, Chantal; et al. (2011). Blass, John P., ed. Neurochemical Mechanisms in Disease. Springer. pp. 112–3.